IONS

Birchler Brian

Known title: EVP, Corp and Development OpsCIK: 0001970151

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

Cathie Wood adds to Ionis position amid RNA sector interest. Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.

this person other insiders at IONS

Transaction History

IONS▼ Sell$3K
IONS▼ Sell$73K
IONS▲ Buy$0
IONS▼ Sell$17K
IONS▼ Sell$513K
IONS▲ Buy$0
IONS▼ Sell$637K
IONS▲ Buy$0
IONS▼ Sell$609K
IONS▲ Buy$668K
IONS▼ Sell$897K
IONS▲ Buy$617K
IONS▼ Sell$827K
IONS▼ Sell$5K
IONS▼ Sell$19K
IONS▲ Buy$0
IONS▼ Sell$12K
IONS▼ Sell$177K
IONS▲ Buy$0
IONS▼ Sell$464
IONS▼ Sell$38K
IONS▲ Buy$0
IONS▼ Sell$21K
IONS▼ Sell$227K
IONS▲ Buy$0
IONS▲ Buy$544K
IONS▼ Sell$557K
IONS▼ Sell$25K
IONS▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.